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malities in renal proximal tubular (PT) sodium transport play an
important role in the pathophysiology of essential hypertension. The
Na/H exchanger isoform 3 (NHE3) represents the major route for
sodium entry across the apical membrane of renal PT cells. We
therefore aimed to assess in vivo NHE3 transport activity and to
define the molecular mechanisms underlying NHE3 regulation before
and after development of hypertension in the spontaneously hyper-
tensive rat (SHR). NHE3 function was measured as the rate of
bicarbonate reabsorption by means of in vivo stationary microperfu-
sion in PT from young prehypertensive SHR (Y-SHR; 5-wk-old),
adult SHR (A-SHR; 14-wk-old), and age-matched Wistar Kyoto
(WKY) rats. We found that NHE3-mediated PT bicarbonate reabsorp-
tion was reduced with age in the SHR (1.08  0.10 vs. 0.41  0.04
nmol/cm2s), while it was increased in the transition from youth to
adulthood in the WKY rat (0.59 0.05 vs. 1.26 0.11 nmol/cm2s).
Higher NHE3 activity in the Y-SHR compared with A-SHR was
associated with a predominant microvilli confinement and a lower
ratio of phosphorylated NHE3 at serine-552 to total NHE3 (P-NHE3/
total). After development of hypertension, P-NHE3/total increased
and NHE3 was retracted out of the microvillar microdomain along
with the regulator dipeptidyl peptidase IV (DPPIV). Collectively, our
data suggest that the PT is playing a role in adapting to the hyperten-
sion in the SHR. The molecular mechanisms of this adaptation
possibly include an increase of P-NHE3/total and a redistribution of
the NHE3-DPPIV complex from the body to the base of the PT
microvilli, both predicted to decrease sodium reabsorption.
sodium transport; proximal tubule; blood pressure; phosphorylation;
dipeptidyl peptidase IV
MAINTENANCE OF EXTRACELLULAR volume homeostasis depends
upon the kidneys to precisely balance sodium excretion with
dietary sodium intake. To accomplish this task, the activities of
a number of sodium transport proteins along the nephron are
tightly regulated. The proximal tubule (PT) accounts for reab-
sorption of65% of the filtered water and of most solutes. The
Na/H exchanger isoform 3 (NHE3) represents the major
route for sodium entry and H secretion in this nephron
segment (5, 6, 30, 37, 40–42). NHE3 also has a major role in
mediating NaCl reabsorption in the PT through its combined
activity with a Cl/base exchanger (2, 43) and by creating an
increase in luminal chloride concentration that favors the
diffusion of the anion from the tubular lumen to the blood.
NHE3-mediated Na/H exchange is therefore the predomi-
nant PT mechanism for NaHCO3 and NaCl reabsorption.
Micropuncture analysis on NHE3 knockout mice revealed a
remarkable reduction of PT fluid (60%) and bicarbonate
(50%) reabsorption (30, 40–42). Consequently, mice lacking
NHE3 exhibit reduced blood pressure, mild acidosis, elevated
serum aldosterone, and elevated mRNA encoding renal renin.
Despite a chronic volume-depleted state, NHE3 knockouts fed
on a regular sodium diet are viable mostly due to reduced
glomerular filtration rate (GFR) and increased sodium and
bicarbonate reabsorption in the distal nephron (27, 37). Nev-
ertheless, when these mice are submitted to dietary sodium
restriction, the adaptive responses are not sufficient to fully
compensate for the large defect on PT reabsorption, and they
display significant urinary sodium wasting and sharply reduced
blood pressure and may undergo hypovolemic shock (27).
Given the important role of NHE3 in mediating sodium and
fluid reabsorption, this transporter is subject to acute and
chronic regulation in response to a variety of conditions affect-
ing salt balance, including volume contraction (9), high salt
intake (33, 45), and hypertension (16, 21, 25, 46). Using an
experimental animal model of chronic volume contraction,
Fisher et al. (9) observed that NHE3 expression is significantly
upregulated in the renal cortex at both protein and mRNA
levels. As part of the kidney’s natriuretic response to restore
volume homeostasis, NHE3 activity is downregulated in rats
fed a high-sodium diet (33). Reduced NHE3 activity in re-
sponse to high-sodium intake is associated with increased
levels of NHE3 phosphorylated at serine-552 and redistribution
of the transporter out of the brush-border microvilli (MMV), a
transport-relevant domain of apical membrane, together with
its associated protein dipeptidyl peptidase IV (DPPIV) (45).
Conflicting data have been reported with regard to NHE3
modulation in genetic models of essential hypertension. Stud-
ies using ex vivo (25) and in vitro (21) approaches have shown
that NHE3 activity is upregulated at all stages of hypertension
in spontaneously hypertensive rats (SHR). Conversely, studies
by the McDonough and Yip laboratories (31, 44, 46) have
consistently reported that NHE3 is redistributed from the body
to the base of the MMV in this rat lineage during the hyper-
tensive stage. This shift is accompanied by increases of lithium
clearance, a marker for volume flow out of the PT (31),
suggesting that NHE3 redistribution is associated with de-
creased PT sodium reabsorption. If so, rather than contributing
to development and maintenance of hypertension, NHE3 plays
a protective role counterbalancing blood pressure rising in the
A-SHR.
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In the present report, in vivo stationary microperfusion was
employed to assess NHE3 transport function in the native PT
of young prehypertensive and adult hypertensive SHR. Molec-
ular mechanisms known to be important in regulation of
NHE3, including direct protein phosphorylation and subcellu-
lar redistribution with the interacting protein DPPIV, were also
investigated before and after development of hypertension in
the SHR strain.
MATERIALS AND METHODS
Reagents and antibodies. Reagents were obtained from Sigma (St.
Louis, MO) unless otherwise specified. S3226 was a gift from Sanofi-
Aventis (Frankfurt, Germany). A monoclonal antibody (mAb) to rat
DPPIV, clone 5E8, a mouse mAb anti-PS552, clone 14D5 (23), as
well as goat-polyclonal anti-villin were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). mAb raised to the renal brush-
border NHE3 (6) was purchased from Millipore (Billerica, MA) and
mAb to actin (JLA20) was purchased from Merck (Darmstadt, Ger-
many). A rabbit polyclonal anti-megalin antibody was kindly pro-
vided by Dr. Daniel Biemesderfer at Yale University, New Haven,
CT. Horseradish peroxidase-conjugated goat anti-mouse, goat anti-
rabbit, and rabbit anti-goat secondary antibodies were purchased from
Invitrogen (San Diego, CA).
Animal protocols. Animal procedures and protocols were followed
in accordance with the ethical principles in animal research of the
Brazilian College of Animal Experimentation and were approved by
the institutional animal care and use committee. Experiments were
performed using young (5-wk-old) and adult (14-wk-old) male SHRs
and age-matched normotensive control Wistar-Kyoto (WKY) rats.
Rats were housed under standardized conditions (constant tempera-
ture of 22°C, 12:12-h light-dark cycle, and relative humidity of 60%)
at the University of São Paulo Medical School animal facility. Blood
pressure in conscious restrained rats was measured noninvasively by
tail cuff plethysmography (BP-2000 Blood Pressure Analysis System;
Visitech Systems, Apex, NC). Prior to these measurements, rats were
trained in the blood pressure device to become adapted to the exper-
imental procedures and to renal function assessment, rats were placed
in metabolic cages during three consecutive days. Urine samples
collected during each 24-h period were used to determine urinary
flow, GFR, urinary sodium excretion, and endogenous lithium clear-
ance. Arterial blood samples were collected from carotid arteries at
the time of death for measurements of sodium, lithium, and creatinine
concentration. Sodium was measured on a 9180 Electrolyte Analyzer
(Roche Diagnostics, Mannheim, Germany). Flame photometry (model
B262; Micronal, São Paulo, Brazil) was performed to obtain lithium
concentrations. Creatinine was measured on a Synchron CX7 Ana-
lyzer (Beckman Coulter, Fullerton, CA). Creatinine clearance was
used to estimate GFR. Endogenous lithium clearance was calculated
as V  ULi/PLi where V is urine output, ULi is urinary lithium
concentration, and PLi is plasma lithium concentration.
In vivo stationary microperfusion. Rats were anesthetized by intra-
muscular administration of tiletamine-zolazepam (30 mg/kg). The left
jugular vein was cannulated for infusion of mannitol-saline at a rate of
0.1 ml/min. The kidney was exposed by a lumbar approach and
prepared for in vivo micropuncture. PTs were perfused by means of
double-barreled micropipettes: one barrel was filled with Sudan Black
colored castor oil, and the other, with an FDC green-colored solution
of 100 mm NaCl and 25 mm NaHCO3 (perfusion solution). To
minimize fluid reabsorption, this solution had been rendered isotonic
through the addition of raffinose. The rate of tubular acidification was
measured by injecting a droplet of the perfusion solution between the
oil columns and following the luminal pH changes toward the steady-
state level (stationary perfusion). Luminal pH was measured by means
of double-barreled microelectrodes, one barrel being filled with H
ionophore (cocktail B; Fluka, Buchs, Switzerland) and the other with
reference solution colored by FDC green. The voltage between the
microelectrode barrels, representing luminal H activity, was contin-
uously recorded with a microcomputer equipped with an analog-to-
digital conversion board (Lynx, São Paulo, Brazil) for data acquisition
and processing. Bicarbonate concentration was calculated from pH
and from measured arterial PCO2. The rate of tubular acidification was
calculated as the half-time of the reduction of the injected HCO3
concentration to its stationary level (t1/2). The net bicarbonate reabsorp-








where t1/2 is the acidification half-time; (HCO3)0 and (HCO3)s are
the injected concentration of bicarbonate and steady-state bicarbonate
concentration respectively; and r is the tubular radius.
Real-time RT-PCR. Total RNA was isolated from renal cortices as
previously described (36). First-strand cDNA synthesis was performed
with Super-Script III Reverse Transcriptase following the manufacturer’s
guidelines. Fifteen nanogram cDNAs were used for real-time RT-PCR
reaction (SYBR Green PCR Master Mix-PE; Applied Biosystems) in an
ABI Prism 7700 Sequence Detection System (Applied Biosystems). All
samples were assayed in triplicate. The control gene 28S ribosomal RNA
was used to normalize the results. The comparative threshold cycle
method was used for data analyses. Oligonucleotide primers used were as
follows: NHE3, 5=-ACTGCTTA-ATGACGCGGTGACTGT-3= (for-
ward) and 5=-AAAGACGAAGCCAGGCTCGATGAT-3= (reverse); and
28S, 5=-TCATCAGACCCCAGAAAAGG-3= (forward) and 5=-
GATTCGGCAGGTGAGTTG-3= (reverse).
Isolation of renal cortical microsomes. Rats were euthanized by
intraperitoneal injection of pentobarbital sodium. Kidney cortices
were isolated at 4°C and homogenized in PBS containing 1 tablet/50
ml of complete protease inhibitor cocktail tablets (Roche, Mannheim,
Germany) and phosphatase inhibitors (50 mM NaF and 15 mM
sodium pyrophosphate) at pH 7.4. The homogenate was centrifuged at
2,000 g for 15 min at 4°C. The supernatant was removed and
subjected to a further 1 h of centrifugation at 100,000 g at 4°C to pellet
the microsomal fraction. The supernatant was discarded, and the
microsomes were resuspended in fresh PBS containing protease and
phosphatase inhibitors.
Microvillar membrane vesicle preparation. Rat kidney cortices
were isolated at 4°C and homogenized in a K-HEPES buffer (200 mM
mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5) containing protease
and phosphatase inhibitors (as above). Microvillus membrane vesicles
were prepared using a method based on Mg2 precipitation and
differential centrifugation as described previously (1).
Preparation of renal membrane fractions. Postmitochondrial renal
cortical microsomes were prepared and separated on 15–30% Opti-
Prep (Nycomed Pharma, Oslo, Norway) gradients, essentially as
described previously (4). One-milliliter fractions were manually col-
lected from the top and assayed by immunoblotting for the presence
of villin, megalin, NHE3, and DPPIV. Figure 1 illustrates the density
separation of cortical microsomes from an 14-wk-old WKY (A-
WKY) rat obtained by isopycnic centrifugation. Fraction 1, which
was enriched in the microvillar membrane marker villin (low-density
gradient fraction), was pelleted by centrifugation and resuspendend in
K-HEPES buffer. High-density fractions, which were enriched in
megalin were pooled from fractions 5–6 in the gradient, pelleted, and
then resuspended in K-HEPES buffer. The same procedure was
repeated to prepare membrane fractions from Y- and A-SHR and of
Y-WKY rats (data not shown).
SDS-PAGE and immunoblotting. Proteins were solubilized in SDS-
PAGE sample buffer and subjected to SDS-PAGE using 7.5% poly-
acrylamide gels. Proteins were subsequently transferred to polyvinyli-
dene fluoride membranes (Immobilon-P; Millipore). Nonspecific
binding was blocked by incubating the polyvinylidene fluoride mem-
brane at room temperature for 1 h in Blotto (5% nonfat dry milk and
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0.1% Tween 20 in PBS, pH 7.4) followed by overnight incubation
with 1:1,000 anti-PS552 (23), 1:1,000 anti-NHE3 (6), 1:1,000 anti-
DPPIV, 1:50,000 anti-megalin, or 1:50,000 anti-actin at 4°C in Blotto.
The membranes were then washed five times with Blotto and incu-
bated for 1 h with horseradish peroxidase-conjugated immunoglobulin
secondary antibody (1:2,000). Membranes were again washed five
times with Blotto and then rinsed in PBS. Bound antibody was
detected with enhanced chemiluminescence (GE Healthcare) accord-
ing to the manufacturer’s protocols. The visualized bands were digi-
tized using the ImageScanner III (GE HealthCare) and quantified
using Image software (Scion, Frederick, MD). The amount of sample
to optimally detect phosphorylated NHE3, total NHE3, and actin in
the linear range was chosen based on the experiments shown in
supplementary Fig. S1 (supplemental data for this article are available
online at the American Journal of Physiology–Renal Physiology
website.).
Statistics. All results are reported as means  SE with n indicating
the number of observations. Comparisons between two groups were
performed using unpaired t-tests. If more than two groups were
compared, statistical significance was determined by ANOVA fol-
lowed by Tukey’s post hoc test. A P value  0.05 was considered
significant. The program “Graph Pad Prism 5” (Graph Pad Software,
San Diego, CA) was used to calculate significance.
RESULTS
Blood pressure and renal function. Blood pressure in SHR
and WKY rats was measured by tail cuff plethysmography.
As depicted in Table 1, systolic blood pressure was slightly
but significantly higher in 5-wk-old SHR (Y-SHR) than in
age-matched Y-WKY (113  4 vs. 91  2 mmHg, P 
0.05), whereas adult SHR (A-SHR) had markedly higher
systolic blood pressure than a A-WKY (189  5 vs. 106 
4 mmHg, P  0.001). Although systolic blood pressure was
elevated in Y-SHR compared with the normotensive control,
these rats had not yet developed hypertension. Fourteen-
week-old A-SHRs, on the other hand, were already hyper-
tensive.
Urine output, GFR, urinary sodium excretion, and lithium
clearance were significantly lower in Y-SHR compared with
Y-WKY (Table 1). The mean values of urine output, sodium
excretion, and GFR were lower in A-SHR relative to A-WKY,
but none of these parameters reached statistical significance.
Conversely, lithium clearance was significantly higher in the
A-SHR (P  0.001 vs. A-WKY) (Table 1).
PT NHE3-mediated bicarbonate reabsorption. The in vivo
NHE3 transport activity was measured as the rate of bicarbon-
ate reabsorption in the native PT by means of stationary
microperfusion. Experiments were performed either in the
presence or absence of 2 M S3226, a selective NHE3 inhib-
itor (38). Figure 2A attests that the rate of bicarbonate flux
(JHCO3) in luminal-perfused PTs of Y-SHR was significantly
higher than in Y-WKY (1.9  0.19 vs. 1.36  0.13 nmol/
cm2s, P  0.05). Elevated NHE3 transport activity did not
persist during SHR adulthood. As seen in Fig. 2A, PT bicar-
bonate reabsorption was significantly lower in A-SHR com-
pared with A-WKY (1.21 0.09 vs. 2.04 0.19 nmol/cm2s,
P  0.001). The S3226-insensitive bicarbonate reabsorption
component was equivalent between these two rat strains. The
difference in JHCO3 between SHR and WKY was even more
pronounced when only the NHE3-mediated-bicarbonate reab-
sorption was taken into account (the S3226-sensitive compo-
nent of PT bicarbonate reabsorption, i.e., total reabsorption
minus reabsorption in the presence of S3226) (Fig. 2B). Results
shown in Fig. 2B demonstrate that in vivo NHE3 transport
Fig. 1. Density separation of renal cortical microsomes from adult Wistar-
Kyoto (A-WKY) rats. Renal cortical microsomes were separated by isopycnic
centrifugation using 15–30% OptiPrep density gradients. Fractions (1 ml) were
collected across the gradient, and 25 l of each was prepared for SDS-PAGE
and immunoblotting. Fraction 1 represents the top (lightest fraction) and
fraction 8 represents the bottom (densest fraction) of the gradient. The same
blot was probed successively with antibodies for megalin, villin, Na/H
exchanger isoform 3 (NHE3), and dipeptidyl peptidase IV (DPPIV). Fraction
1 [microvillus (MMV) membranes], which was enriched in the MMV mem-
brane marker villin, was pelleted by centrifugation. Dense vesicles [intermi-
crovilli vesicles (IMV)], which are enriched in megalin, were pooled from
fractions 5–6 in the gradient.
Table 1. Body weight, blood pressure, and renal function of spontaneously hypertensive rats (SHRs) and Wistar-Kyoto
(WKY) rats at 5 wk (Y) and 14 wk of age (A)
Y-WKY Y-SHR A-WKY A-SHR
Body Weight, g 132  5 (16) 98  3* (18) 301  8 (16) 272  5* (16)
SBP, mmHg 91  2 (12) 113  4* (18) 106  4 (15) 189  5* (16)
Urine output, l·min1·kg1 52  4 (12) 34  2* (18) 37  2 (15) 31  2 (16)
GFR, ml·min1·kg1 8.8  0.4 (12) 7.9  0.3* (18) 6.3  0.4 (16) 5.9  0.4 (16)
Urinary Na, meq·min1·kg1 8.6  0.3 (12) 5.7  0.2* (18) 5.6  0.4 (16) 5.2  0.3 (16)
Li clearance, l·min1·kg1 161  14 (12) 116  4* (18) 69  4 (15) 103  10* (16)
Values are means  SE. Number in parentheses is number of animals per group. Systolic blood pressure (SBP) was measured noninvasively by tail cuff
plethysmography. Rats were placed in metabolic cages for collection of 24-h urine samples. Urine output was measured gravimetrically. Creatinine clearance was
used to estimate glomerular filtration rate (GFR). Renal functional data were corrected by body weight and expressed as grams per kilogram body wt. *P  0.01 vs.
age matched WKY.
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activity was 83  7% higher in Y-SHR than in Y-WKY (P 
0.001) and 67  5% lower in A-SHR compared with A-WKY
(P  0.001). In Table 2, the data presented above is displayed
and statistically analyzed with regard to age-dependent
changes on NHE3 function. Interestingly, NHE3 activity was
reduced in the transition from Y-SHR to A-SHR (62  6%),
while it was increased in the transition between Y-WKY and
A-WKY (113  10%) (Fig. 2B, Table 2).
Renal cortical NHE3-mRNA expression. The relative amount of
NHE3-mRNA in renal cortex from SHR and WKY rats was
determined by real-time RT-PCR using specific primers corre-
sponding to the rat NHE3 COOH-terminal region. The expression
of NHE3 transcript was normalized by 28S-RNA. As depicted in
Table 2, the expression levels of NHE3-mRNA in renal cortex did
not vary significantly between SHR and WKY at both 5 and 14
wk of age. Table 2 also shows that NHE3-mRNA expression was
significantly higher in both A-SHR and A-WKY rats relative to
their young counterparts. This pattern is also consistently ob-
served at the protein level (Table 2, Fig. 3, A and B), as previously
reported by Magyar et al. (31).
Fig. 2. Bicarbonate reabsorption (JHCO3) in renal proximal
tubule (PT) from membranes from 5-wk-old SHR (Y-SHR),
14-wk-old SHR (A-SHR), and age-matched WKY rats. JHCO3
was evaluated by means of stationary microperfusion and
continuous measurement of luminal pH in the absence or
presence of 2 M S3226. Numbers of perfused tubules are
indicated in the bars. Data are means  SE. *P  0.05; **P 
0.001 vs. Y-WKY; #P 0.05; ##P 0.001 vs. A-WKY. Renal
PT JHCO3 (A) and S3226-sensitive component of PT JHCO3
(B) are shown.
Table 2. Age-dependent changes on proximal tubular Na/H exchanger isoform 3 (NHE3) transport activity and
NHE3-mRNA, protein expression and endogenous phosphorylation levels in renal cortex of SHR and WKY rats
Y-WKY A- WKY Y- SHR A-SHR
Transport activity, nmol/cm2s 0.59  0.05 (9) 1.26  0.11* (9) 1.08 0.10 (9) 0.41  0.04* (12)
mRNA levels, AU 0.27  0.03 (3) 0.57  0.05* (3) 0.23 0.04 (3) 0.53  0.06* (3)
Protein abundance, AU 0.76  0.09 (5) 1.11  0.07* (5) 0.78 0.09 (5) 1.14  0.09* (5)
P-NHE3/total, AU 0.57 0.01 (5) 0.32  0.02* (5) 0.35 0.01 (5) 0.60  0.02* (5)
Values are means  SE. Number in parentheses is number of perfused tubules or animals per group. Proximal tubular (PT) NHE3 transport activity was
measured by stationary in situ microperfusion and is expressed as the mean values of the S3226-sensitive component of PT bicarbonate reabsorption.
NHE3-mRNA was measured by real-time PCR and 28S-RNA was used as internal control. Total and phosphorylated NHE3 (P-NHE3) were assessed by
immunoblotting in renal cortical microsomes. The mean values of relative NHE3 expression normalized to actin and of the phosphorylated NHE3 to total NHE3
ratio (P-NHE3/total) are expressed in arbitrary units (AU). *P  0.001 vs. young counterpart assessed by unpaired t-test.
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Expression of total and phosphorylated NHE3 at serine-552
in renal cortical microsomes. Examination of the phosphory-
lation status of NHE3 was performed by immunoblotting by
using a phosphospecific monoclonal antibody that recognizes
NHE3 only when it is phosphorylated at serine-552 (23). As
seen in Fig. 3, A and C, the relative ratio of phosphorylated
NHE3 at serine-552 to total NHE3 (P-NHE3/total) was lower
in renal cortical microsomes from Y-SHR compared with
Y-WKY (61  3%, P  0.001). In contrast, A-SHR displayed
higher P-NHE3/total in renal cortex than A-WKY (87  3%,
P  0.001). The results shown in Figs. 2–3 and in Table 2
demonstrate that changes on the P-NHE3/total ratio in renal
cortical microsomes from SHR and WKY rats inversely cor-
related with changes on NHE3 function. When considering this
ratio in terms of age dependence, it is noticeable that the
P-NHE3/total ratio increases with age in SHR (71  2%, P 
0.001), whereas it decreases from youth to adulthood in the
WKY (56  2%, P  0.001) (Table 2, Fig. 3C).
Expression of total and P-NHE3 in PT MMV membranes
vesicles. The NHE3 phosphorylation status and protein content
were also evaluated within the PT brush-border MMV pre-
pared from SHR or WKY rats. Figure 4 shows that total NHE3
expression in Y-SHR MMV membranes was higher (56 7%,
P  0.001) and that the relative ratio of P-NHE3/total was
significantly lower than in Y-WKY (64  3%, P  0.001)
group. After development of hypertension, A-SHR exhibited
lower MMV NHE3 expression (69  6%, P  0.001) (Fig. 4,
A and B) and a higher P-NHE3/total ratio (71  5%, P 
0.001) than A-WKY (Fig. 4, A and C).
Subcellular distribution of NHE3 and DPPIV. The distribu-
tion of NHE3 and DPPIV within the brush-border subcompart-
ments was evaluated in SHR and WKY by means of subcel-
lular fractionation and immunoblotting. The immunoblotting
experiments were performed using equal amounts of protein
from either MMV or intermicrovilli (IMV) separated from
SHR and WKY rats as described in MATERIALS AND METHODS.
Illustrated in Fig. 5, A–D, villin is predominantly expressed in
MMV, while megalin is more highly expressed in the IMV
than in the MMV domain. The distribution of these markers
did not alter with respect to either age or rat strain. As shown
in Fig. 5, E and F, NHE3 was practically equally distributed
between the MMV and IMV microdomains in both Y- and
A-WKY. As previously determined by microscopy (46) and
density gradient fractionation (31), this pattern of distribution
was altered in the SHR. Consistent with the immunoblotting
experiments using microvillus membrane vesicles isolated by
divalent cation precipitation (Fig. 4), we found that NHE3 was
predominantly confined to the MMV microdomain of the PT
brush-border in Y-SHR (Fig. 5E). In contrast, A-SHR exhib-
ited higher NHE3 expression in the IMV-enriched fraction
(Fig. 5F). As observed in Fig. 5, G and H, DPPIV is much
more abundant in MMV than in IMV in both SHR and WKY.
However, the distribution of this peptidase discretely changes
between these brush-border subcompartments in the SHR
Fig. 3. Expression of total and phosphorylated
Na/H exchanger isoform 3 (P-NE3) at serine-
552 in renal cortical microsomes from Y-SHR,
A-SHR, and age-matched WKY rats. Equiva-
lent samples (15 g for NHE3; 5 g for
PS552-NHE3, and 2.5 g for actin) of renal
cortical microsomes isolated from A- and Y-
SHR and WKY rats were subjected to SDS-
PAGE, transferred to a polyvinylidene fluoride
(PVDF) membrane and analyzed by immuno-
blotting. A: representative immunoblot of
NHE3 phosphorylation and expression in renal
cortical microsomes. Membranes were incu-
bated with monoclonal antibodies against P-
NHE3 at serine-552 (1:1,000), total NHE3
(1:1,000), and anti-actin (1:50,000). Graphical
representation of the relative expression levels
of total NHE3 normalized to actin (B) and of
the ratio of P-NHE3 at serine-552 to total
NHE3 (P-NHE3/total) (C) in renal cortical
microsomes. Values are means  SE; n 
5/group, *P 0.001 vs. Y-WKY; #P 0.001
vs. A-WKY.
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strain. In the Y-SHR, 81% of DPPIV is confined to the MMV,
while 19% resides in the IMV-enriched fraction. Microvillar
DPPIV expression was slightly but significantly higher in
Y-SHR than in Y-WKY (16  1%, P  0.01) and lower in
A-SHR vs. A-WKY (18  2%, P  0.01). With regard to
age-related changes in DPPIV distribution, we found that the
percentage of the peptidase that resides in the MMV microdo-
main decreased from 81 to 65%, and the one that is confined to
the IMV increased from 19 to 35% in the transition from youth
to adulthood in the SHR. The distribution of DPPIV did not
differ significantly with age in the WKY rats.
DISCUSSION
Results presented here indicate that the NHE3 transport
function is higher in the PT of SHR prior to the development
of hypertension and lower thereafter compared with the age-
matched normotensive WKY rats. Remarkably, NHE3 activity
is reduced with age in the SHR, while it is increased in the
transition between Y- and A-WKY. Higher NHE3 activity in
the prehypertensive Y-SHR (compared to either Y-WKY or
A-SHR) is accompanied by enhanced NHE3 expression in the
brush-border MMV, where the transporter physically associ-
ates with the regulator DPPIV (10) and lower phosphorylation
levels of serine-552. In the A-SHR, all of these regulatory
mechanisms seem to work in an opposite fashion to reduce PT
sodium reabsorption. Our data are consistent with the notion
that enhanced PT NHE3 activity contributes to the onset of
hypertension in the Y-SHR (16, 21, 25, 39). Nevertheless, once
hypertension is established, reduced NHE3 activity represents
an integral part of the pressure-natriuresis response to counter-
act blood pressure rising (31, 44, 46).
Sodium retention and volume expansion play an important
role in the pathogenesis of essential hypertension (32). Our
data show that renal function is substantially altered in the
prehypertensive Y-SHR. These animals exhibited lower GFR,
which led to less sodium to be filtered and excreted compared
with age-matched WKY rats. Besides, lithium clearance was
reduced, suggesting that PT sodium reabsorption is increased.
By means of stationary in situ microperfusion, we found that
NHE3-mediated bicarbonate reabsorption was80% higher in
5-wk-old SHR compared with age-matched WKY. These data
confirm previous reports describing elevation of NHE3 activity
before onset of hypertension in genetic models of essential
hypertension (16, 21, 25, 39).
Once hypertension is established, the differences between
A-SHR and A-WKY rats with respect to urine output, urinary
sodium excretion, and GFR are much more attenuated and do
not reach statistical significance. However, lithium clearance is
increased, suggesting that PT sodium reabsorption is lower.
Accordingly, NHE3-mediated bicarbonate reabsorption in re-
nal PT was 70% diminished in the hypertensive A-SHR
compared with age-matched WKY. Our findings are in contrast
to those of LaPointe et al. (25) and Kobayashi et al. (21) who
demonstrated that NHE3 activity persists, stimulated after
development of hypertension in SHR. Such discrepancy is
likely attributed to the fact that our functional studies were
Fig. 4. Expression of total and P-NHE3 at
serine-552 in brush-border MMV membranes
from Y-SHR, A-SHR, and age-matched WKY
rats. Equivalent samples (15 g for NHE3; 5
g for PS552-NHE3, and 2.5 g for actin) of
MMV prepared by divalent cation aggregation
from WKY and SHR were subjected to SDS-
PAGE, transferred to a PVDF membrane, and
analyzed by immunoblotting. A: representative
immunoblot of NHE3 phosphorylation and ex-
pression in kidney MMV. The membranes
were incubated with monoclonal antibod-
ies against P-NHE3 at serine-552 (1:
1,000), total NHE3 (1:1,000), and anti-
actin (1:50,000). Graphical representation
of the relative expression levels of total
NHE3 normalized to actin (B) and of the
ratio of P-NHE3/total (C) in microvillar
membranes. Values are means  SE; n 
5/group, *P  0.001 vs. Y-WKY; #P 
0.001 vs. A-WKY.
F877POSTTRANSLATIONAL REGULATION OF NHE3 IN SHR
AJP-Renal Physiol • VOL 299 • OCTOBER 2010 • www.ajprenal.org
performed in the native PT in contrast to cell culture models
(21) or ex vivo preparations (25). Although in vitro models are
very valuable tools to isolate and dissect single effects, the
applicability of them for the elucidation of integrative physio-
logical and pathological processes may be limited. Further-
more, inhibition of NHE3 activity in the A-SHR may depend
on factors, which may not be present or functional in ex vivo
preparations. In line with our findings, Panico et al. (35) very
recently demonstrated that PT fluid reabsorption is reduced in
the A-SHR by 60% compared with age-matched WKY. The
authors proposed that diminished fluid reabsorption in the
A-SHR was related to increased reactive oxygen species, since
direct microperfusion of reducing agents restored PT transport
function in these animals (35).
Numerous studies have aimed to investigate the molecular
basis for sodium retention in the SHR kidney. With regard
to NHE3 modulation, most of these reports have not found
significant differences of NHE3 transcripts or protein abun-
dance between SHR and normotensive strains (20, 31, 35,
46). In agreement with this, we have not noticed any
significant variation of the levels of NHE3 expression be-
tween SHR and same-age WKY rats. Interestingly, NHE3-
mRNA and protein expression were significantly higher in
both A-SHR and A-WKY rats relative to their young coun-
terparts. This increment is probably due to the developmen-
tal changes of NHE isoforms in postnatal PT (3). Although
NHE3 function and expression increased concurrently with
age in the WKY, such direct correlation could not be
observed in the SHR (Table 2). It implies that changes of
NHE3 activity during the age interval of 5 to 14 wk in the
hypertensive rat strain are mainly caused by posttransla-
tional mechanisms.
Fig. 5. Distribution of NHE3 and DPPIV in the
renal brush-border microdomains of Y-SHR, A-
SHR, and age-matched WKY rats. Equal quan-
tities (20 g protein) of MMV and IMV pre-
pared from Y (A, C, E, and G)- or A (B, D, F,
and H)-SHR and WKY rat kidneys by density
fractionation of postmitochondrial microsomes
were analyzed by immunoblotting. Blots were
probed with antibodies to villin (A and B), mega-
lin (C and D), NHE3 (E and F), and DPPIV (G and
H). Values are means  SE; n  5/group; *P 
0.01 vs. MMV-WKY, #P 0.01 and ##P 0.05
vs. IMV-WKY.
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Phosphorylation of the serine-552 residue in the COOH-
terminal region of NHE3 seems to be necessary for PKA to
exert inhibition of the exchanger (23). One of the major new
findings of our study is that changes in NHE3 activity occur
concurrently with changes of NHE3 phosphorylation status in
the SHR model. In prehypertensive Y-SHR, the relative ratio
of P-NHE3/total in renal cortical microsomes were signifi-
cantly lower compared with WKY (70%) and similar in
magnitude to NHE3 transport stimulation (80%). When con-
sidering this quotient in terms of age dependence, the P-NHE3/
total ratio increased with age in SHR (70%), correlating well
with the reduction of NHE3 activity (60%). These results
suggest that increased NHE3 function in the Y-SHR PT is
attributable to abnormalities in signaling pathways that either
prevent activation of kinases or overactivate phosphatases.
There is evidence that the ability of dopamine-1 receptor
agonists to inhibit NHE3 in renal PT and induce natriuresis is
impaired in the SHR (29). In these animals, the dopamine-1
receptor is uncoupled from its effector adenylyl cyclase and
thus fails to activate PKA. Changes in the phosphorylation
status of renal proteins involved in sodium transport are not
unprecedented. Similar to NHE3, the phosphorylation of the
Na/K-ATPase 	-1 subunit at serine-18 is decreased in the
Y-SHR PT (17). This altered pattern of phosphorylation in-
creases the recruitment of the 	-1 subunit of the Na/K-
ATPase to the basolateral membrane and consequently en-
hances PT sodium reabsorption (26). It has been postulated that
increased apical sodium entry via NHE3 induces a coordinate
Fig. 5—Continued
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rise in the activity of the Na/K-ATPase contributing to
sodium retention and blood pressure rising in the Y-SHR (17).
The finding that elevation of intracellular sodium concentration
leads to Na/K-ATPase dephosphorylation strengthens this
hypothesis (19).
Inhibition of NHE3 by cAMP requires the presence of either
NHE regulatory factor-1 (NHERF1) or NHERF2 to allow the
catalytic subunit of PKA II to phosphorylate NHE3 (24, 48). It
has been previously shown that NHERF2 expression is in-
creased at both protein (35) and mRNA levels (21) after
development of hypertension in the SHR PT. The higher
expression of the PDZ scaffold protein NHERF2 may be
related to the higher levels of phosphorylated NHE3 and
reduced activity of the transporter in the A-SHR renal cortex.
Phosphorylation of the 552 residue of NHE3 has been
implicated in NHE3 subcellular trafficking (22, 23). Accord-
ingly, we found that in prehypertensive Y-SHR, MMV NHE3
expression is higher than in the IMV cleft. Conversely, in
hypertensive A-SHR, NHE3 is mainly confined to the IMV
microdomain. Our data support those of other laboratories (31,
45, 46) that have demonstrated that acute and chronic hyper-
tension provoke redistribution of NHE3 from the body to the
base of MMV.
We previously discovered that a significant pool of NHE3
physically associates with DPPIV in renal PT (10) and that
inhibition of DPPIV downregulates NHE3 activity (11, 12). A
variety of conditions that affect salt balance and change NHE3
subcellular localization alters DPPIV distribution as well (28,
31, 44–46), including a coordinate redistribution of DPPIV
and NHE3 out of the MMV-enriched membranes during the
development of hypertension in the SHR (31). Thus it is
conceivable that assembly of NHE3 with DPPIV is lower when
the NHE3-mediated Na/H exchange is reduced. These ob-
servations also suggest that the peptidase may also play a role
in volume homeostasis and blood pressure control. In line with
this observation, our laboratory has recently demonstrated that
exendin-4, an agonist of the glucagon-like peptide-1 (GLP-1)
receptor, inhibits NHE3 activity in PT cells (7). GLP-1 is a
DPPIV substrate, and it has been shown by us and others to be
involved in sodium homeostasis (7, 14, 15, 18, 34, 47). Of
note, both GLP-1 and exendin-4 have antihypertensive actions
(18, 47). Whether inhibition of DPPIV may attenuate the rising
of blood pressure and whether this is due to increased GLP-1
half-life remains to be determined.
NHE3 and DPPIV do not directly bind to each other,
indicating that additional accessory proteins are required for
the association to occur (13). It is conceivable that one of these
accessory proteins mediates the dynamic subcellular trafficking
of the NHE3-DPPIV complex in response to physiological and
pathophysiological stimuli. In fact, Leong et al. (28) have
demonstrated that the cytoskeleton proteins myosin-IIA (non-
muscle) and myosin VI retract out of the MMV along with
NHE3 and DPPIV in response to the ACE inhibitor captopril.
Further studies are needed to evaluate whether these molecular
motor proteins are capable of physically associating with
NHE3 and DPPIV.
We conclude that NHE3 activity decreases with age in the
SHR, while increasing with age in the WKY. The fall in
activity in SHR is associated with an increase in direct phos-
phorylation of the transporter and subcellular distribution out
of the MMV along with its regulator DPPIV. The elucidation
of the signaling pathways that control phosphorylation of
sodium transport proteins and of binding partners that mediate
their subcellular trafficking may unravel important mecha-
nisms implicated in the pathophysiology of essential hyperten-
sion.
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